Ergomed (ERGO)

 

Latest News

Holdings in Company

RNS Number: 5074B Ergomed plc 10 January 2018 TR-1: S tandard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Ergomed Plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the notification (pleas...

Ergomed appoints chief exec and COO

Ergomed has announced changes to its board and management team with the appointment of Stephen Stamp as chief exe...

Board changes

RNS Number: 4305Z Ergomed plc 15 December 2017 PRESS RELEASE Board changes Stephen Stamp appointed as CEO and Jan Petracek as COO London, UK - 15 December 2017: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a specialised pharmaceutical services and drug development company, today announces changes to its Board and management tea...

Ergomed co-development partnership with Allergy Therapeutics

Ergomed has announced a multi-product, multi-study co-development partnership with Allergy Therapeutics to support th...

All News

DateHeadlineSource
10-01-18Holdings in CompanyRNS
15-12-17Ergomed appoints chief exec and COOStockMarketWire
15-12-17Board changesRNS
12-12-17Ergomed co-development partnership with Allergy TherapeuticsStockMarketWire
12-12-17Co-dev partnership with Allergy TherapeuticsRNS
04-12-17Ergomed's PrimeVigilance hosts automation seminarStockMarketWire
04-12-17Ergomed's PrimeVigilance hosts automation seminarRNS
27-11-17Ergomed presents at German Equity Forum StockMarketWire
27-11-17Ergomed to present at the German Equity Forum 2017RNS
23-10-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
23-10-17Ergomed's PeproStat reports positive resultsStockMarketWire
23-10-17Ergomed's PeproStat reports positive resultsRNS
12-10-17Holding(s) in CompanyRNS
06-10-17Broker Forecast - Numis issues a broker note on Ergomed PlcStockMarketWire
03-10-17Ergomed completes acquisition of PSR StockMarketWire
03-10-17Completion of Acquisition of PSR Group BVRNS
28-09-17Ergomed conditionally raises £2.9mStockMarketWire
28-09-17Result of PlacingRNS
28-09-17Acquisition of PSR Group BV and PlacingRNS
27-09-17Commercialisation Deal on Haemostatix ProductsRNS
18-09-17Ergomed net service revenues up 53%StockMarketWire
18-09-17Interim ResultsRNS
21-08-17CEL-SCI Corporation issues restricted sharesRNS
14-08-17Ergomed's partner to resume Phase 3 study of MultikineStockMarketWire
14-08-17FDA removal of hold on Ph3 trial with MultikineRNS
14-08-17Ergomed schedules interim results StockMarketWire
14-08-17Notice of ResultsRNS
24-07-17Ergomed completes study recruitment ahead of schedule StockMarketWire
24-07-17Recruitment complete early for Phase IIb studyRNS
04-07-17Investor MeetingRNS
21-06-17PeproStat study passes recruitment mid-pointRNS
19-06-17Ergomed resolutions passed at AGMStockMarketWire
16-06-17Result of AGMRNS
16-06-17Ergomed appoints CEOStockMarketWire
16-06-17Appointment of CEORNS
13-06-17Ergomed to present at the Shares Spotlight Evening in Manchester on 29 June 2017StockMarketWire
22-05-17Appointment of N+1 Singer as joint brokerRNS
12-05-17Annual Report and Notice of AGMRNS
08-05-17Ergomed updates in PharmInvent earn-outStockMarketWire
08-05-17Issue of Shares to Former PharmInvent ShareholdersRNS

RSS feeds

  • Editorial news feed for LSE:ERGO Editorial
  • Regulatory news feed for LSE:ERGO Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account